Silodosin

赛洛多辛

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameSilodosin
Drug Alias NameThrupas西洛多新silodosina西洛多辛西罗多辛 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsContraception BehaviorNocturiaLower Urinary Tract Symptoms +[9] 
Global Approved IndicationsProstatic Hyperplasia
Approved Indications in ChinaProstatic Hyperplasia
Original Approved Country/TerritoryJapan
Original Approved Date2006/01/23
Country/TerritoryUnited StatesSyriaEgypt +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSyrian Private UniversityMansoura UniversityBenha University +[9] 
Inactive CompaniesAbbvie IncRecordati SpaAmerican Watson Pharmaceutical Co Ltd
Active IndicationsContraception BehaviorLower Urinary Tract SymptomsUrolithiasis +[5] 
Inactive IndicationsNocturiaUrinary CalculiUreteral Calculi +[4] 

Other Information

ATC CodeG04CA04
Related LinksWikipediaDrugBankKEGG